Capstone Holding

Capstone Holding EBIT Margin

The EBIT Margin (Operating Margin) of Capstone Holding (CAPS) as of Oct 28, 2026 is -7.64 %. In the previous year, EBIT Margin (Operating Margin) was -1.42 % — a change of 437.58% (lower).

EBIT Margin

-7.64 %

YoY

437.58%

Last updated:

EBIT Margin (Operating Margin) of Capstone Holding is 2025 -7.64 % . EBIT Margin (Operating Margin) of Capstone Holding was 2024 -1.42 % . It decreases by 437.58% lower compared to the previous year.

For Capstone Holding, the operating (EBIT) margin of -7.6% is down versus 6.9% a few years ago.

The Capstone Holding EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-27.70 USD
Jan 1, 2019
-5.45 USD
Jan 1, 2020
5.27 USD
Jan 1, 2021
6.95 USD
Jan 1, 2022
6.49 USD
Jan 1, 2023
-4.25 USD
Jan 1, 2024
-1.42 USD
Jan 1, 2025
-7.64 USD
The Capstone Holding EBIT Margin history
YEAREBIT MarginYoY
-7.64 %+437.58%
-1.42 %-66.56%
-4.25 %-165.55%
6.49 %-6.62%
6.95 %+31.76%
5.27 %-196.64%
-5.45 %-80.31%
-27.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Capstone Holding Stock analysis

What does Capstone Holding do? Capstone Therapeutics Corp. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for unmet medical needs. The company was founded in 1987 and is headquartered in Tempe, Arizona. It began as a research project at Arizona State University, eventually leading to the founding of the company. Capstone Therapeutics utilizes its technology platform in peptide chemistry, cell biology, and pharmacology to develop therapies for diseases with limited treatment options. Its core business includes developing medications for neurodegenerative diseases like Alzheimer's and oncological diseases with no effective treatment options. The company collaborates with other industry leaders in biotechnology and holds a strong intellectual property position. Capstone Therapeutics aims to improve the lives of individuals with serious illnesses through its innovative products and strategic approach. Capstone Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Capstone Holding stock

EBIT Margin (Operating Margin) of Capstone Holding is -7.64 % in 2025.

EBIT Margin (Operating Margin) of Capstone Holding changed from -1.42 % to -7.64 %, representing a 437.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Capstone Holding since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Capstone Holding with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Capstone Holding

All Key Metrics — Capstone Holding